SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide
Clinical trial NCT02953340 · COMPLETED
Trial details
- NCT number
- NCT02953340
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-10
- Primary completion
- 2018-06-08
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.